Navis Wealth Advisors LLC acquired a new stake in Aflac Incorporated (NYSE:AFL – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 3,000 shares of the financial services provider’s stock, valued at approximately $334,000.
A number of other hedge funds also recently modified their holdings of AFL. Southern Capital Advisors LLC grew its position in Aflac by 11.6% in the 1st quarter. Southern Capital Advisors LLC now owns 36,330 shares of the financial services provider’s stock valued at $4,040,000 after purchasing an additional 3,763 shares during the period. Consolidated Portfolio Review Corp purchased a new position in shares of Aflac during the first quarter valued at approximately $377,000. Capitol Family Office Inc. bought a new stake in Aflac during the first quarter worth $86,000. Legacy Advisors LLC lifted its stake in Aflac by 6.4% during the 1st quarter. Legacy Advisors LLC now owns 2,625 shares of the financial services provider’s stock valued at $292,000 after acquiring an additional 159 shares in the last quarter. Finally, Asset Management One Co. Ltd. grew its stake in shares of Aflac by 5.3% in the 1st quarter. Asset Management One Co. Ltd. now owns 228,301 shares of the financial services provider’s stock worth $25,385,000 after acquiring an additional 11,577 shares in the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.
Analysts Set New Price Targets
AFL has been the topic of several research reports. JPMorgan Chase & Co. lifted their price objective on shares of Aflac from $94.00 to $96.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 2nd. Piper Sandler upped their price target on Aflac from $118.00 to $124.00 and gave the company an “overweight” rating in a research report on Wednesday, April 2nd. Keefe, Bruyette & Woods lifted their price objective on Aflac from $104.00 to $106.00 and gave the stock a “market perform” rating in a report on Wednesday, May 7th. Barclays boosted their price objective on Aflac from $95.00 to $96.00 and gave the company an “underweight” rating in a research note on Thursday, May 1st. Finally, Raymond James Financial cut their target price on shares of Aflac from $115.00 to $110.00 and set an “outperform” rating for the company in a research report on Thursday, May 29th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $104.93.
Insider Transactions at Aflac
In other news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction on Thursday, May 8th. The stock was sold at an average price of $106.79, for a total transaction of $106,790.00. Following the completion of the transaction, the director now directly owns 26,096 shares in the company, valued at $2,786,791.84. This trade represents a 3.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Masatoshi Koide sold 37,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the completion of the transaction, the director now owns 70,992 shares of the company’s stock, valued at approximately $7,496,045.28. The trade was a 34.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 40,750 shares of company stock valued at $4,304,295. Company insiders own 0.80% of the company’s stock.
Aflac Trading Up 1.5%
Shares of AFL opened at $104.89 on Tuesday. The firm has a fifty day simple moving average of $104.84 and a two-hundred day simple moving average of $105.22. Aflac Incorporated has a twelve month low of $88.00 and a twelve month high of $115.50. The stock has a market capitalization of $56.71 billion, a P/E ratio of 16.39, a PEG ratio of 3.20 and a beta of 0.82. The company has a quick ratio of 0.09, a current ratio of 0.09 and a debt-to-equity ratio of 0.29.
Aflac (NYSE:AFL – Get Free Report) last posted its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing analysts’ consensus estimates of $1.67 by ($0.01). Aflac had a return on equity of 15.55% and a net margin of 21.27%. The firm had revenue of $3.40 billion for the quarter, compared to analysts’ expectations of $4.53 billion. During the same quarter in the prior year, the company posted $1.66 earnings per share. The business’s revenue for the quarter was down 37.5% on a year-over-year basis. On average, research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current year.
Aflac Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st were given a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date of this dividend was Wednesday, May 21st. Aflac’s payout ratio is currently 36.25%.
Aflac Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Read More
- Five stocks we like better than Aflac
- Compound Interest and Why It Matters When Investing
- Microsoft Stock Holds Steady as AI Drives Workforce Shift
- Investing in Travel Stocks Benefits
- D-Wave Goes International With South Korea Partnership
- Top Biotech Stocks: Exploring Innovation Opportunities
- Payment Giants Slide on Stablecoin Buzz—Is Now the Time to Buy?
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.